鼻咽癌放疗相关淋巴细胞减少与生存的相关性:治疗方式和基线淋巴细胞计数的影响
该回顾性研究纳入2004至2015年接受根治性放疗的374例II-IVa期鼻咽癌患者,评估放疗期间G3-4级淋巴细胞减少(ALC<0.5×10^9 cells/L)与患者、肿瘤及治疗因素的关系。多因素分析显示较低基线ALC和IMRT是与G3-4级RIL相关的独立因素;G3-4级ALC最低值与更长LRFS和PFS独立相关,而G4级ALC最低值与更短DMFS独立相关。
要点
- 较低基线ALC和IMRT是与放疗期间G3-4级淋巴细胞减少相关的独立因素
- G3-4级ALC最低值与更长LRFS(HR=0.548,P=0.005)和PFS(HR=0.676,P=0.022)独立相关
- G4级ALC最低值与更短DMFS独立相关(HR=2.567,P=0.037)
核心结论
- 放疗期间淋巴细胞减少受基线ALC和放疗方式独立影响。
- G3-4级ALC最低值与更长PFS和LRFS独立相关,G4级ALC最低值与更短DMFS独立相关。
研究设计与样本
- 回顾性研究纳入374例II-IVa期鼻咽癌患者,2004至2015年接受根治性放疗。
- 采用Cox回归分析G3-4级RIL与患者、肿瘤及治疗因素的关系,Kaplan-Meier分析和log-rank检验比较ALC最低值与生存,并用Cox比例风险分析确认。
主要发现
- 多因素分析中,较低基线ALC和IMRT(对比2D-CRT)是与G3-4级RIL相关的2个独立因素。
- 多因素生存分析中,G3-4级ALC最低值患者较G0-2级有更长LRFS(HR=0.548,P=0.005)和更长PFS(HR=0.676,P=0.022)。
- G4级ALC最低值患者较G0-2级有更短DMFS(HR=2.567,P=0.037)。
关键数值与推荐
- G3-4级RIL定义为放疗期间绝对淋巴细胞计数(ALC)<0.5×10^9 cells/L。
临床怎么用
- 鼻咽癌根治性放疗中应关注基线ALC和放疗方式对淋巴细胞减少的影响。
- 放疗期间ALC最低值分级可能与生存结局相关,或可辅助治疗策略调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We evaluated the relationship between patient-, tumor-, and treatment-related features and radiation-induced lymphopenia (RIL) and evaluated the correlation between RIL and survival outcome in NPC patients to help improve the treatment strategy. METHODS: This retrospective study included 374 patients with stage II-IVa NPC who had been treated with definitive RT and were enrolled from 2004 to 2015; The associations between the G3-4 RIL (absolute lymphocyte count, ALC < 0.5 × 109 cells/L) during RT and patient-, tumor-, and treatment-related factors were assessed using Cox regression analyses. The correlation between ALC nadir and survival was examined using a Kaplan-Meier analysis, compared with the log-rank test, and confirmed by a Cox proportional hazards analysis. RESULTS: In the multivariate analysis, lower baseline ALC and intensity modulated radiation therapy (IMRT) (vs. 2 dimensional-conformal radiation therapy,2D-CRT) were identified as 2 independent factors that were associated with G3-4 RIL. In the multivariate survival analysis, patients with G3-4 ALC nadir had longer local recurrence-free survival durations (LRFS) (vs. G0-2 nadir, HR = 0.548, P = 0.005) and longer progression-free survival durations (PFS) (vs. G0-2 nadir, HR = 0.676, P = 0.022), while patients with G4 ALC nadir had a shorter distant-metastasis-free survival duration (DMFS) (vs. G0-2 nadir, hazard ratio [HR] = 2.567, P = 0.037). CONCLUSIONS: In the study, lymphopenia during RT were affected by baseline ALC and RT modality independently. Moreover, G3-4 ALC nadir was independently linked with longer PFS and LRFS durations, while G4 ALC nadir was independently linked with a shorter DMFS duration.
引用
- Xie X, Gong S, Jin H, et al. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count. Radiat Oncol. 2020. PMID: 32169088. doi:10.1186/s13014-020-01494-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。